Generic Prescription Drugs
The generic pharmaceutical and store-brand helath products maker Perrigo Co. (NYSE: PRGO) Thursday reported net income of $111.4 million or $1.18 a share in the first fiscal quarter ended Sept. 28, up from $105.6 million or $1.12 a share in the first fiscal quarter a year earlier. Revenue was $933.4 million, up from $769.8 million a year earlier.
Perrigo Co. (Nasdaq: PRGO) Thursday announced that its board of directors declared a quarterly dividend of 9 cents a share.
The generic drug and health and beauty product manufacturer Perrigo Co. Tuesday reported record revenue and profit for the second fiscal quarter ended Dec. 31.
Allegan-based Perrigo Co. reported record revenue of $2.76 billion for its fiscal year ended June 25, up 21 percent or $487 million from $2.27 billion a year earlier.